Implication of the melanocortin-3 receptor in the regulation of food intake.

[1]  N. Rowland,et al.  Food demand and meal size in mice with single or combined disruption of melanocortin type 3 and 4 receptors. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[2]  J. Hoyer,et al.  Modulation of blood pressure by central melanocortinergic pathways. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  I. Pogozheva,et al.  Melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 modified at the para position of the benzyl side chain (DPhe): importance for mouse melanocortin-3 receptor agonist versus antagonist activity. , 2008, Journal of medicinal chemistry.

[4]  V. Hruby,et al.  Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression , 2008, Peptides.

[5]  M. Kas,et al.  AgRP(83–132) and SHU9119 differently affect activity-based anorexia , 2006, European Neuropsychopharmacology.

[6]  R. Cone,et al.  The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R) , 2006, Peptides.

[7]  W. Millard,et al.  Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist. , 2004, Journal of medicinal chemistry.

[8]  Andrzej Wilczynski,et al.  Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. , 2004, Journal of medicinal chemistry.

[9]  E. Air,et al.  Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII , 2003, International Journal of Obesity.

[10]  Zhimin Xiang,et al.  Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position. , 2002, Journal of medicinal chemistry.

[11]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[12]  Y. Wan,et al.  Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. , 2001, Biochemistry.

[13]  C. Haskell-Luevano,et al.  Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor , 2001, Regulatory Peptides.

[14]  S. Woods,et al.  Immediate and Prolonged Patterns of Agouti-Related Peptide-(83-132)-Induced c-Fos Activation in Hypothalamic and Extrahypothalamic Sites. , 2001, Endocrinology.

[15]  Victor J. Hruby,et al.  D-amino acid scan of γ-melanocyte-stimulating hormone : Importance of Trp8 on human MC3 receptor selectivity , 2000 .

[16]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[17]  R. Cone,et al.  A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.

[18]  S. Woods,et al.  Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  S. Woods,et al.  Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockade. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[20]  Y. Wan,et al.  The agouti-related protein decapeptide (Yc[CRFFNAFC]Y) possesses agonist activity at the murine melanocortin-1 receptor , 2000, Peptides.

[21]  R. Palmiter,et al.  Effects of neuropeptide Y deficiency on hypothalamic agouti-related protein expression and responsiveness to melanocortin analogues , 1999, Brain Research.

[22]  R. Cone,et al.  Integration of NPY, AGRP, and Melanocortin Signals in the Hypothalamic Paraventricular Nucleus Evidence of a Cellular Basis for the Adipostat , 1999, Neuron.

[23]  V. Hruby,et al.  Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. , 1998, The Journal of urology.

[24]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[25]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[26]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[27]  S. O’Rahilly,et al.  Modulation of blood pressure by central melanocortinergic pathways. , 2009, The New England journal of medicine.

[28]  C. Haskell-Luevano,et al.  Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position. , 2002, Journal of medicinal chemistry.

[29]  R. Adan,et al.  AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor. , 2001, Molecular endocrinology.

[30]  R. Cone,et al.  A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. , 2000, Endocrinology.

[31]  R. Palmiter,et al.  Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides , 1999, Nature Genetics.

[32]  R. Seeley,et al.  Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[33]  M. Low,et al.  Receptors for the melanocortin peptides in the central nervous system , 1994 .